ClearPoint Neuro: director Timothy T. Richards received 319 shares

What happened

• The Form 4 states Timothy T. Richards, a director of ClearPoint Neuro, received 319 shares at $12.21 per share on Oct 1, 2026, for a total value of $3,895. The Form 4 was filed on Oct 2, 2026.

Key details

• Transaction date and price: Oct 1, 2026; $12.21 per share; total $3,895.
• Shares owned after the transaction: not reported in this filing.
• Footnote: the filing states the shares were issued pursuant to the issuer's Seventh Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed under the issuer's Non-Employee Director Compensation Plan, and were issued at the closing price of the common stock on Sep 30, 2026.
• Filing date: Oct 2, 2026.

Why it may matter

• The transaction code reported is A (award/grant); the shares were issued as payment of fees and are not reported as a market purchase or sale.
• This filing does not show why the insider traded or why the company acted.